Abbott expects a ‘few hundred million’ in tariff costs in 2025

CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.

By Elise Reuter • April 16, 2025

US launches probe into semiconductor imports

The Section 232 investigation comes ahead of anticipated tariffs on the industry.

By Philip Neuffer • April 15, 2025

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

J&J expects tariff charge of $400M this year

CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare giant’s medtech business.

By Ricky Zipp • April 15, 2025

J&J completes first surgeries with Ottava robot

Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which was performed in the clinical trial.

By Susan Kelly • April 15, 2025

Edwards receives CE mark for Sapien M3 mitral valve replacement device

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s Mitraclip.

By Nick Paul Taylor • April 15, 2025

Tariffs top of mind for medtech firms this earnings season

GE Healthcare and Medtronic said they are preparing mitigation plans as they assess the potential ramifications of Trump’s tariff policies.

By Susan Kelly • April 14, 2025

Late-stage digital health funding rebounds in Q1: Rock Health

The median deal size for late-stage funding rounds was $105 million, nearly double the $55 million check size across 2024.

By Emily Olsen • April 14, 2025

Intuitive wins FDA clearance for single-port robotic surgery stapler

CFO Jamie Samath said in January that the stapler clearance would trigger the start of “broad commercial efforts” for the single-port system.

By Nick Paul Taylor • April 11, 2025

Tariff turmoil: Hospitals, device makers welcome pause, but fear long-term pain

Healthcare providers and medtech companies still face pressure to find ways to offset potential supply chain shocks despite the latest about-face in President Donald Trump’s tariff wars.

By Susanna Vogel , Susan Kelly • April 10, 2025

Dexcom nets FDA clearance for 15-day CGM

The longer wear time should improve Dexcom’s margins and help it compete with Abbott, RBC Capital Markets analyst Shagun Singh said.

By Elise Reuter • April 10, 2025

Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader

Microbot reported positive data on its single-use endovascular robot. Elsewhere, GE Healthcare named a new business leader, and Puzzle Medical Devices raised $31 million.

By Nick Paul Taylor • April 10, 2025

Teleflex to close Minnesota facility, cut 101 employees

The restructuring plan comes about six weeks after Teleflex announced it would split into two separate, public entities.

By Elise Reuter • April 10, 2025

Trump pauses most reciprocal tariffs, hikes China’s further

The U.S. will now charge a 125% duty on imports from China, while most other countries will be subject to a 10% rate for 90 days.

By Philip Neuffer • April 10, 2025

Trump’s tariffs: Tracking the status of international trade actions

The U.S. has rolled out a deluge of tariffs, sparking responses from trading partners. Here’s where each tariff — threatened or realized — currently stands.

By Philip Neuffer , Edwin Lopez • April 9, 2025

Kandu Health merges with BCI company Neurolutions

The merger brings together Neurolutions’ brain computer interface technology and Kandu Health’s telehealth services to try to improve stroke care.

By Nick Paul Taylor • April 9, 2025

AdvaMed continues pressure on White House to exempt devices from tariffs

Amid the whirlwind of tariff news, AdvaMed and other healthcare groups have pleaded for the Trump administration to exempt medical devices and critical supplies.

By Ricky Zipp • April 8, 2025

J&J starts IVL trial in ‘difficult-to-cross’ coronary arteries

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it emits waves from its tip.

By Nick Paul Taylor • April 8, 2025

Trump threatens 50% tariff on China if retaliatory duties stay

The president said China has until Tuesday to back off from its plan for 34% tariffs on U.S. imports.

By Max Garland • April 8, 2025

China probes US-made CT tubes after Trump hikes tariffs

The investigation indicates that China will likely favor local medtech companies over foreign competition amid international economic tensions, a J.P. Morgan analyst said.

By Elise Reuter • Updated April 9, 2025

Enovis appoints Damien McDonald as CEO

McDonald, who is set to start as CEO on May 12, is joining a business that has expanded quickly in the orthopedic reconstruction sector.

By Nick Paul Taylor • April 7, 2025

A ‘wobbly’ moment in business: Manufacturers face life under Trump’s tariffs

Companies are pushing to be more agile and flexible as the Trump administration’s baseline 10% tariff takes effect, but challenges loom ahead.

By Kate Magill • April 4, 2025

Tariffs send healthcare industry into ‘unchartered waters’

Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain. Wall Street, meanwhile, said medtech businesses will face pressure, particularly diabetes tech firms.

By Susanna Vogel , Susan Kelly • April 4, 2025

China readies 34% tariff on US imports starting April 10

The country’s retaliation against President Donald Trump’s trade policies builds upon previously announced duties.

By Max Garland • April 4, 2025

Eargo, Hearx merge into one OTC hearing aid firm, receive $100M boost

Hearx, the maker of Lexie hearing aids, and Eargo competed for the OTC hearing aid market created by the FDA in 2022.

By Nick Paul Taylor • April 3, 2025

Dr. Oz confirmed to lead CMS

Dr. Mehmet Oz, a physician and TV personality, will lead the agency during a turbulent time for federal health programs as the HHS lays off thousands of staffers and Republicans float potential cuts to Medicaid.

By Emily Olsen • Updated April 4, 2025